PathMaker Neurosystems Inc. is a near-commercial stage neuromodulation company that aims to develop non-invasive devices to treat Spasticity and ALS. The company's flagship product, MyoRegulator, is the world's first non-invasive neuromodulation device for the treatment of muscle spasticity. PathMaker is headquartered in Boston (US) and Paris (France), and is focused on rapidly bringing to market novel, breakthrough approaches to non-invasive treatment of serious neurological disorders. Founded in 1907, the company operates within the Biotechnology and Health Care industries, with its most recent $2.16M grant investment, obtained from the U.S. Department of Defense on 05 June 2024.
PathMaker Neurosystems Inc.
PathMaker is a near-commercial stage neuromodulation company developing non-invasive devices to treat Spasticity and ALS
Founded 2015
Boston, United States
2 employees
Grant
Total: $2.16M
Biotechnology, Health Care +1
Boston, United States
2 employees
Grant
Total: $2.16M
Biotechnology, Health Care +1
General Information
Company Name
PathMaker Neurosystems Inc.
Founded Year
2015
Location
Boston, United States
Boston, United States
Employees
2
Industries
Biotechnology, Health Care, Life Sciences
Funding Stage
Grant
BounceWatch is an independent company data service, not affiliated with PathMaker Neurosystems Inc.. To contact PathMaker Neurosystems Inc., visit pmneuro.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does PathMaker Neurosystems Inc. compare?
A PDF of PathMaker Neurosystems Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting PathMaker Neurosystems Inc. soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biotechnology
About PathMaker Neurosystems Inc.
Business keywords: neuromodulation, neurotechnology, non-invasive, neuromotor disorders, bioelectronic medicine, ALS, Spasticity, neuronal hyperexcitability suppression, trans-Atlantic strategy, neuroscience, Boston, Paris, MyoRegulator, muscle spasticity, neuronal hyperexcitability
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | $2.16M | 1 |
U.S. Department of Defense
|
05 Jun 2024 |
PathMaker Neurosystems Inc. Alternatives & Competitors
PathMaker Neurosystems Inc. vs
FAQ About PathMaker Neurosystems Inc.
PathMaker is a near-commercial stage neuromodulation company developing non-invasive devices to treat Spasticity and ALS
PathMaker Neurosystems Inc. was founded in 2015.
PathMaker Neurosystems Inc. is headquartered in Boston, United States.
PathMaker Neurosystems Inc. operates in Biotechnology, Health Care and Life Sciences. Its work centres on neuromodulation, neurotechnology, non-invasive and neuromotor disorders.
PathMaker Neurosystems Inc. has approximately 2 employees.
PathMaker Neurosystems Inc. has completed 1 funding round, raising a total of $2.16M. The latest funding stage is Grant.
Top alternatives and competitors to PathMaker Neurosystems Inc. include Parasym. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PathMaker Neurosystems Inc. and Parasym are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for PathMaker Neurosystems Inc., https://bouncewatch.com/company/pathmaker-neurosystems-inc, updated 25 November 2024. When citing, please name BounceWatch and link this page.
